|
2025-01-02 |
2025-01-02 |
B
Purchase
|
EcoR1 Capital, LLC
Non-Executive Director
Large shareholder
|
6,646
+0.1%
12.95
USD 86,070
|
6,646
+0.1%
|
12.95
|
USD 86,070
|
|
|
2025-01-02 |
2024-12-31 |
B
Purchase
|
EcoR1 Capital, LLC
Non-Executive Director
Large shareholder
|
13,268
+0.2%
12.93
USD 171,513
|
13,268
+0.2%
|
12.93
|
USD 171,513
|
|
|
2025-01-02 |
2024-12-30 |
B
Purchase
|
EcoR1 Capital, LLC
Non-Executive Director
Large shareholder
|
65,184
+0.8%
12.92
USD 842,060
|
65,184
+0.8%
|
12.92
|
USD 842,060
|
|
|
2024-12-03 |
2024-11-29 |
PS
Planned sale
|
RENTON HOLLINGS
Non-Executive Director
|
10,000
-83.7%
25.00
USD 250,000
|
10,000
-83.7%
|
25.00
|
USD 250,000
|
|
|
2024-09-24 |
2024-09-23 |
PS
Planned sale
|
Lizzul Paul F.
Chief Medical Officer
Officer
|
1,500
-8.9%
38.67
USD 58,005
|
1,500
-8.9%
|
38.67
|
USD 58,005
|
|
|
2024-09-17 |
2024-09-17 |
PS
Planned sale
|
LOUMEAU ERIC J
CHIEF LEGAL OFFICER
Officer
|
3,780
-53.8%
38.41
USD 145,191
|
3,780
-53.8%
|
38.41
|
USD 145,191
|
|
|
2024-09-17 |
2024-09-16 |
S
Sale
|
Lizzul Paul F.
Chief Medical Officer
Officer
|
2,220
-12.6%
38.93
USD 86,425
|
2,220
-12.6%
|
38.93
|
USD 86,425
|
|
|
2024-09-17 |
2024-09-16 |
PS
Planned sale
|
LOUMEAU ERIC J
CHIEF LEGAL OFFICER
Officer
|
6,500
-48.1%
40.13
USD 260,845
|
6,500
-48.1%
|
40.13
|
USD 260,845
|
|
|
2024-09-17 |
2024-09-16 |
S
Sale
|
LOUMEAU ERIC J
CHIEF LEGAL OFFICER
Officer
|
2,220
-20.7%
38.93
USD 86,425
|
2,220
-20.7%
|
38.93
|
USD 86,425
|
|
|
2024-09-17 |
2024-09-16 |
PS
Planned sale
|
MULROY DENNIS
CHIEF FINANCIAL OFFICER
Officer
|
10,000
-67.8%
40.13
USD 401,300
|
10,000
-67.8%
|
40.13
|
USD 401,300
|
|
|
2024-09-17 |
2024-09-16 |
S
Sale
|
MULROY DENNIS
CHIEF FINANCIAL OFFICER
Officer
|
2,220
-31.9%
38.93
USD 86,425
|
2,220
-31.9%
|
38.93
|
USD 86,425
|
|
|
2024-08-16 |
2024-08-14 |
PS
Planned sale
|
Lizzul Paul F.
Chief Medical Officer
Officer
|
2,000
-14.7%
40.00
USD 80,000
|
2,000
-14.7%
|
40.00
|
USD 80,000
|
|
|
2024-08-16 |
2024-08-14 |
B
Purchase
|
EcoR1 Capital, LLC
Large shareholder
|
273,972
+3.6%
36.50
USD 9,999,978
|
273,972
+3.6%
|
36.50
|
USD 9,999,978
|
|
|
2024-07-19 |
2024-07-18 |
PS
Planned sale
|
Lizzul Paul F.
Chief Medical Officer
Officer
|
1,500
-11.4%
35.00
USD 52,500
|
1,500
-11.4%
|
35.00
|
USD 52,500
|
|
|
2024-07-17 |
2024-07-15 |
PS
Planned sale
|
RENTON HOLLINGS
Non-Executive Director
|
2,897
-59.8%
30.98
USD 89,754
|
2,897
-59.8%
|
30.98
|
USD 89,754
|
|
|
2024-07-17 |
2024-07-15 |
PS
Planned sale
|
RENTON HOLLINGS
Non-Executive Director
|
7,103
-59.4%
30.50
USD 216,668
|
7,103
-59.4%
|
30.50
|
USD 216,668
|
|
|
2024-06-24 |
2024-06-21 |
PS
Planned sale
|
FENTON DENNIS M
Non-Executive Director
|
1,950
-50.0%
23.17
USD 45,182
|
1,950
-50.0%
|
23.17
|
USD 45,182
|
|
|
2024-06-18 |
2024-06-18 |
PS
Planned sale
|
RENTON HOLLINGS
Non-Executive Director
|
1,950
-50.0%
23.16
USD 45,162
|
1,950
-50.0%
|
23.16
|
USD 45,162
|
|
|
2024-05-24 |
2024-05-22 |
PS
Planned sale
|
MULROY DENNIS
CHIEF FINANCIAL OFFICER
Officer
|
1,500
-60.9%
23.72
USD 35,580
|
1,500
-60.9%
|
23.72
|
USD 35,580
|
|
|
2024-03-26 |
2024-03-25 |
S
Sale
|
Faga Daniel
CEO
Executive Director
|
3,000
-0.4%
21.42
USD 64,268
|
3,000
-0.4%
|
21.42
|
USD 64,268
|
|
|
2024-03-26 |
2024-03-22 |
S
Sale
|
Faga Daniel
CEO
Executive Director
|
145,940
-16.3%
22.78
USD 3,325,185
|
145,940
-16.3%
|
22.78
|
USD 3,325,185
|
|
|
2024-02-21 |
2024-02-16 |
PS
Planned sale
|
LOUMEAU ERIC J
CHIEF LEGAL OFFICER
Officer
|
5,000
-60.7%
25.00
USD 125,000
|
5,000
-60.7%
|
25.00
|
USD 125,000
|
|
|
2024-02-01 |
2024-01-30 |
PS
Planned sale
|
MULROY DENNIS
CHIEF FINANCIAL OFFICER
Officer
|
3,065
-76.1%
23.63
USD 72,425
|
3,065
-76.1%
|
23.63
|
USD 72,425
|
|
|
2024-01-09 |
2024-01-08 |
S
Sale
|
MULROY DENNIS
Chief Financial Officer
Officer
|
2,180
-35.1%
21.81
USD 47,546
|
2,180
-35.1%
|
21.81
|
USD 47,546
|
|
|
2024-01-09 |
2024-01-08 |
S
Sale
|
Faga Daniel
CEO
Executive Director
|
6,866
-0.8%
21.81
USD 149,747
|
6,866
-0.8%
|
21.81
|
USD 149,747
|
|
|
2024-01-09 |
2024-01-08 |
S
Sale
|
Lizzul Paul F.
Chief Medical Officer
Officer
|
2,554
-20.2%
21.81
USD 55,703
|
2,554
-20.2%
|
21.81
|
USD 55,703
|
|
|
2024-01-09 |
2024-01-08 |
S
Sale
|
LOUMEAU ERIC J
Chief Legal Officer
Officer
|
2,305
-41.6%
21.81
USD 50,272
|
2,305
-41.6%
|
21.81
|
USD 50,272
|
|
|
2023-11-27 |
2023-11-22 |
PS
Planned sale
|
LOUMEAU ERIC J
Chief Legal Officer
Officer
|
882
-100.0%
14.19
USD 12,516
|
882
-100.0%
|
14.19
|
USD 12,516
|
|
|
2023-09-18 |
2023-09-18 |
PS
Planned sale
|
LOUMEAU ERIC J
Chief Legal Officer
Officer
|
3,895
-81.5%
19.32
USD 75,232
|
3,895
-81.5%
|
19.32
|
USD 75,232
|
|
|
2023-09-18 |
2023-09-18 |
PS
Planned sale
|
MULROY DENNIS
Chief Financial Officer
Officer
|
3,895
-80.2%
19.32
USD 75,237
|
3,895
-80.2%
|
19.32
|
USD 75,237
|
|
|
2023-09-18 |
2023-09-14 |
S
Sale
|
LOUMEAU ERIC J
Chief Legal Officer
Officer
|
2,105
-30.6%
19.48
USD 41,005
|
2,105
-30.6%
|
19.48
|
USD 41,005
|
|
|
2023-09-18 |
2023-09-14 |
S
Sale
|
MULROY DENNIS
Chief Financial Officer
Officer
|
2,105
-30.2%
19.48
USD 41,005
|
2,105
-30.2%
|
19.48
|
USD 41,005
|
|
|
2023-09-18 |
2023-09-14 |
S
Sale
|
Lizzul Paul F.
Chief Medical Officer
Officer
|
2,105
-24.4%
19.48
USD 41,005
|
2,105
-24.4%
|
19.48
|
USD 41,005
|
|
|
2022-08-09 |
2022-08-08 |
PS
Planned sale
|
LOUMEAU ERIC J
COO, General Counsel
Officer
|
523
-100.0%
25.00
USD 13,075
|
523
-100.0%
|
25.00
|
USD 13,075
|
|
|
2022-06-10 |
2022-06-08 |
PS
Planned sale
|
LOUMEAU ERIC J
COO, General Counsel
Officer
|
2,500
-82.7%
24.00
USD 60,000
|
2,500
-82.7%
|
24.00
|
USD 60,000
|
|
|
2022-05-20 |
2022-05-18 |
PS
Planned sale
|
LOUMEAU ERIC J
COO, General Counsel
Officer
|
1,146
-68.7%
20.50
USD 23,493
|
1,146
-68.7%
|
20.50
|
USD 23,493
|
|
|
2022-05-09 |
2022-05-05 |
S
Sale
|
EcoR1 Capital, LLC
Large shareholder
|
668,237
-8.2%
21.63
USD 14,453,966
|
668,237
-8.2%
|
21.63
|
USD 14,453,966
|
|
|
2022-05-09 |
2022-05-05 |
B
Purchase
|
EcoR1 Capital, LLC
Large shareholder
|
668,237
+9.8%
21.63
USD 14,453,966
|
668,237
+9.8%
|
21.63
|
USD 14,453,966
|
|
|
2021-12-22 |
2021-12-20 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
5,522
-7.4%
36.40
USD 201,026
|
5,522
-7.4%
|
36.40
|
USD 201,026
|
|
|
2021-12-22 |
2021-12-20 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
19,208
-20.6%
35.75
USD 686,776
|
19,208
-20.6%
|
35.75
|
USD 686,776
|
|
|
2021-12-22 |
2021-12-20 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
11,915
-11.3%
34.89
USD 415,756
|
11,915
-11.3%
|
34.89
|
USD 415,756
|
|
|
2021-11-05 |
2021-11-05 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
14,302
-17.5%
35.00
USD 500,570
|
14,302
-17.5%
|
35.00
|
USD 500,570
|
|
|
2021-11-05 |
2021-11-04 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
6,059
-8.2%
35.00
USD 212,065
|
6,059
-8.2%
|
35.00
|
USD 212,065
|
|
|
2021-11-05 |
2021-11-04 |
PS
Planned sale
|
LOUMEAU ERIC J
COO, General Counsel
Officer
|
5,000
-100.0%
35.00
USD 175,000
|
5,000
-100.0%
|
35.00
|
USD 175,000
|
|
|
2021-11-02 |
2021-11-01 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
2,559
-3.6%
32.88
USD 84,139
|
2,559
-3.6%
|
32.88
|
USD 84,139
|
|
|
2021-11-02 |
2021-11-01 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
34,087
-32.7%
32.27
USD 1,099,967
|
34,087
-32.7%
|
32.27
|
USD 1,099,967
|
|
|
2021-10-28 |
2021-10-26 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
15,993
-19.1%
30.00
USD 479,790
|
15,993
-19.1%
|
30.00
|
USD 479,790
|
|
|
2021-05-04 |
2021-05-04 |
B
Purchase
|
EcoR1 Capital, LLC
Non-Executive Director
Large shareholder
|
165,000
+2.2%
23.25
USD 3,835,755
|
165,000
+2.2%
|
23.25
|
USD 3,835,755
|
|
|
2021-05-04 |
2021-05-03 |
B
Purchase
|
EcoR1 Capital, LLC
Non-Executive Director
Large shareholder
|
20,800
+0.3%
23.31
USD 484,873
|
20,800
+0.3%
|
23.31
|
USD 484,873
|
|
|
2021-05-04 |
2021-04-30 |
B
Purchase
|
EcoR1 Capital, LLC
Non-Executive Director
Large shareholder
|
35,700
+0.5%
23.16
USD 826,816
|
35,700
+0.5%
|
23.16
|
USD 826,816
|
|
|
2021-03-10 |
2021-03-09 |
B
Purchase
|
EcoR1 Capital, LLC
Large shareholder
|
531,000
+8.0%
18.70
USD 9,928,426
|
531,000
+8.0%
|
18.70
|
USD 9,928,426
|
|
|
2021-03-10 |
2021-03-08 |
B
Purchase
|
EcoR1 Capital, LLC
Large shareholder
|
2,777,800
+72.3%
18.97
USD 52,694,310
|
2,777,800
+72.3%
|
18.97
|
USD 52,694,310
|
|
|
2021-02-25 |
2021-02-23 |
B
Purchase
|
EcoR1 Capital, LLC
Large shareholder
|
29,500
+0.8%
25.48
USD 751,657
|
29,500
+0.8%
|
25.48
|
USD 751,657
|
|
|
2021-02-12 |
2021-02-12 |
S
Sale
|
LOUMEAU ERIC J
COO, General Counsel
Officer
|
10,000
-100.0%
35.00
USD 350,000
|
10,000
-100.0%
|
35.00
|
USD 350,000
|
|
|
2020-02-06 |
2019-12-10 |
B
Purchase
|
Ware J. Anthony
|
3,600
+inf%
14.05
USD 50,580
|
3,600
+inf%
|
14.05
|
USD 50,580
|
|
|
2019-06-12 |
2019-06-10 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
454
-2.5%
76.31
USD 34,645
|
454
-2.5%
|
76.31
|
USD 34,645
|
|
|
2019-06-12 |
2019-06-10 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
1,994
-9.9%
75.86
USD 151,271
|
1,994
-9.9%
|
75.86
|
USD 151,271
|
|
|
2019-06-12 |
2019-06-10 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
5,000
-19.9%
74.68
USD 373,413
|
5,000
-19.9%
|
74.68
|
USD 373,413
|
|
|
2019-06-12 |
2019-06-10 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
6,440
-20.4%
73.70
USD 474,637
|
6,440
-20.4%
|
73.70
|
USD 474,637
|
|
|
2019-06-12 |
2019-06-10 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
8,540
-21.3%
72.64
USD 620,385
|
8,540
-21.3%
|
72.64
|
USD 620,385
|
|
|
2019-06-05 |
2019-06-04 |
PS
Planned sale
|
Londei Marco
Chief Medical Officer
|
2,003
-8.2%
74.50
USD 149,219
|
2,003
-8.2%
|
74.50
|
USD 149,219
|
|
|
2019-06-05 |
2019-06-04 |
PS
Planned sale
|
Londei Marco
Chief Medical Officer
|
2,048
-7.7%
73.43
USD 150,384
|
2,048
-7.7%
|
73.43
|
USD 150,384
|
|
|
2019-06-05 |
2019-06-04 |
PS
Planned sale
|
Londei Marco
Chief Medical Officer
|
6,009
-18.5%
72.45
USD 435,359
|
6,009
-18.5%
|
72.45
|
USD 435,359
|
|
|
2019-01-16 |
2019-01-15 |
PS
Planned sale
|
Londei Marco
Chief Medical Officer
Officer
|
14,894
-40.0%
70.04
USD 1,043,195
|
14,894
-40.0%
|
70.04
|
USD 1,043,195
|
|
|
2019-01-16 |
2019-01-15 |
PS
Planned sale
|
Londei Marco
Chief Medical Officer
Officer
|
4,181
-10.1%
69.29
USD 289,686
|
4,181
-10.1%
|
69.29
|
USD 289,686
|
|
|
2019-01-16 |
2019-01-14 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
12,240
-28.9%
71.10
USD 870,304
|
12,240
-28.9%
|
71.10
|
USD 870,304
|
|
|
2019-01-16 |
2019-01-14 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
27,760
-39.6%
70.65
USD 1,961,227
|
27,760
-39.6%
|
70.65
|
USD 1,961,227
|
|
|
2018-12-18 |
2018-12-17 |
PS
Planned sale
|
Londei Marco
Chief Medical Officer
Officer
|
6,741
-4.4%
68.47
USD 461,578
|
6,741
-4.4%
|
68.47
|
USD 461,578
|
|
|
2018-12-18 |
2018-12-17 |
PS
Planned sale
|
Londei Marco
Chief Medical Officer
Officer
|
8,002
-5.0%
67.57
USD 540,684
|
8,002
-5.0%
|
67.57
|
USD 540,684
|
|
|
2018-12-18 |
2018-12-17 |
PS
Planned sale
|
Londei Marco
Chief Medical Officer
Officer
|
3,185
-2.0%
66.38
USD 211,416
|
3,185
-2.0%
|
66.38
|
USD 211,416
|
|
|
2018-12-18 |
2018-12-17 |
PS
Planned sale
|
Londei Marco
Chief Medical Officer
Officer
|
12,120
-6.9%
65.36
USD 792,178
|
12,120
-6.9%
|
65.36
|
USD 792,178
|
|
|
2018-12-18 |
2018-12-14 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
7,800
-20.6%
70.51
USD 549,979
|
7,800
-20.6%
|
70.51
|
USD 549,979
|
|
|
2018-12-18 |
2018-12-14 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
9,084
-19.3%
69.68
USD 632,968
|
9,084
-19.3%
|
69.68
|
USD 632,968
|
|
|
2018-12-18 |
2018-12-14 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
24,844
-34.6%
68.89
USD 1,711,429
|
24,844
-34.6%
|
68.89
|
USD 1,711,429
|
|
|
2018-12-12 |
2018-12-12 |
PS
Planned sale
|
Suria Hamza
President, CEO
Executive Director
|
8,324
-21.7%
72.88
USD 606,618
|
8,324
-21.7%
|
72.88
|
USD 606,618
|
|
